Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 14 Jul 2026 for TransMedics Group, Inc..
Filing timeline
BuySaleNicholas Corcoran
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Nicholas Corcoran: trading record in brief
Nicholas Corcoran discloses dealings in TransMedics Group, Inc. to SEC (Form 4). In total, 10 filings cover trades dated from 20 February 2023 to 10 July 2026.
The open-market record consists of 3 sales worth €2.3M, with no purchase. Besides market trades, the filings include 5 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 14 July 2026: a share grant, in TransMedics Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicholas Corcoran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,727 shares0Common StockSEC:0001193125-26-303713:0
984 shares@ US$135.3011.8% of flowCommon StockSEC:0001193125-26-092182:0
12,676 shares0Common StockSEC:0000950170-25-028054:0
7,810 shares@ US$66.1054.3% of flowCommon StockSEC:0000950170-24-101900:0
3,222 shares@ US$129.9145.7% of flowCommon StockSEC:0000950170-24-055807:0
11,441 shares0Common StockSEC:0000950170-24-021328:0
12,886 shares0Common StockSEC:0000899243-23-005896:0
7 of 7 declarations
